OTCMKTS:BIOQ Bioqual (BIOQ) Stock Price, News & Analysis $32.50 0.00 (0.00%) As of 08/4/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsBuy This Stock About Bioqual Stock (OTCMKTS:BIOQ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bioqual alerts:Sign Up Key Stats Today's Range$32.50▼$32.5050-Day Range$32.50▼$35.0052-Week Range$32.50▼$43.55VolumeN/AAverage VolumeN/AMarket Capitalization$28.93 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Bioqual, Inc. is a U.S.-based contract research organization specializing in preclinical immunology and pharmacology services for the biopharmaceutical industry. The company offers a range of in vivo and in vitro testing solutions designed to support vaccine development, immuno-oncology programs and other therapeutic modalities. Bioqual’s service portfolio encompasses assay development, safety and efficacy studies, biomarker analysis and specialized immunogenicity assessments. Leveraging proprietary humanized animal models and nonhuman primate research platforms, Bioqual helps clients evaluate biological activity, toxicity and pharmacokinetics of investigational compounds. The company’s facilities include vivarium capabilities, tissue culture laboratories and bioanalytical suites configured to meet regulatory standards. Bioqual’s scientific team collaborates with pharmaceutical and biotechnology companies to design study protocols, collect and analyze data, and prepare comprehensive study reports for regulatory submissions. Headquartered in Maryland with additional facilities in California, Bioqual serves a global client base ranging from emerging biotech firms to large pharmaceutical corporations. Its geographically distributed laboratories enable scalable study execution and logistical flexibility. While detailed leadership information is not broadly disclosed, Bioqual’s management is led by seasoned professionals with extensive experience in preclinical development and immunology research.AI Generated. May Contain Errors. Read More Receive BIOQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioqual and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIOQ Stock News HeadlinesBIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2026April 21, 2026 | businesswire.comBIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2026January 22, 2026 | businesswire.comAI billionaires want YOUR electricityMore than 200 utilities, developers and states have joined a voluntary pledge to keep Big Tech's AI power costs off ordinary electric bills. But a pledge doesn't create new electricity. Data centers still need reliable, round-the-clock power, and compact factory-built reactors could fill that gap. See the overlooked companies positioned to supply the fuel and safety systems these reactors need.August 6 at 1:00 AM | Monument Traders Alliance (Ad)PETA files complaint over Mississippi monkey truck crash, citing animal welfare violationsNovember 7, 2025 | msn.comBIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2026October 21, 2025 | businesswire.comBIOQUAL Presents Financial Results for Fiscal Year 2025September 19, 2025 | businesswire.comBioqual, Inc. (BIOQ) stock price, news, quote & history - Yahoo FinanceJuly 10, 2025 | nz.finance.yahoo.comBIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the companyApril 30, 2025 | businesswire.comSee More Headlines BIOQ Stock Analysis - Frequently Asked Questions How have BIOQ shares performed this year? Bioqual's stock was trading at $38.51 at the beginning of the year. Since then, BIOQ stock has decreased by 15.6% and is now trading at $32.50. How were Bioqual's earnings last quarter? Bioqual Inc. (OTCMKTS:BIOQ) posted its earnings results on Tuesday, April, 21st. The company reported ($0.84) EPS for the quarter. The firm earned $9.84 million during the quarter. Bioqual had a negative net margin of 2.27% and a negative trailing twelve-month return on equity of 2.69%. How do I buy shares of Bioqual? Shares of BIOQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bioqual own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioqual investors own include Align Technology (ALGN), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Global X Cloud Computing ETF (CLOU). Company Calendar Last Earnings4/21/2026Today8/06/2026Fiscal Year End5/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolOTCMKTS:BIOQ CIK719711 Webwww.bioqual.com Phone(240) 404-7654FaxN/AEmployees114Year Founded1981Profitability EPS (Trailing Twelve Months)($1.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.05 million Net Margins-2.27% Pretax Margin-3.65% Return on Equity-2.69% Return on Assets-1.50% Debt Debt-to-Equity RatioN/A Current Ratio4.01 Quick Ratio4.01 Sales & Book Value Annual Sales$48.87 million Price / Sales0.59 Cash Flow$1.48 per share Price / Cash Flow21.99 Book Value$40.42 per share Price / Book0.80Miscellaneous Outstanding Shares890,000Free Float543,000Market Cap$28.93 million OptionableNot Optionable Beta-0.20 Social Links 10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (OTCMKTS:BIOQ) was last updated on 8/6/2026 by MarketBeat.com Staff. From Our PartnersThe dollar reset no one told you aboutPorter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-ye...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredControl 100 shares without spending thousands of dollarsWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredHe bet half his $9 billion on ONE stockOne of the most successful fund managers of the past 50 years put more than $4.5 billion - over half his fund ...Stansberry Research | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredA $5 stock inside Kennedy Space Center?A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken...Freedom Financial | SponsoredALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I.Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioqual Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioqual With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
